Award a contract for radx tech - qorvo to secure an EUA approved POC antigen test system as well as increase an incremental daily cartridge production capacity of 54,800 tests.
Ended Definitive Contract Awarded Last action
- Contract number
- 75N92021C00008
- Awardee
-
Qorvo Biotechnologies LLC UEI R9JVQ9VZZEY3 Part of Qorvo, Inc.
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $23,882,600
Award facts
- Opportunity
-
- 75N92021R0026 Solicitation number
- Contract value 100% obligated
- $23,882,600.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Bend, OR, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$2,263,539 | |
| Change Order | -$2,372,000 | |
| Change Order | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $4,158,139 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $24,360,000 |
About this award
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Definitive Firm Fixed Price contract to Qorvo Biotechnologies LLC, a subsidiary of Qorvo, Inc., to secure an Emergency Use Authorization (EUA) approved point-of-care (POC) antigen test system and increase the incremental daily cartridge production capacity to 54,800 tests. The contract, valued at $23,882,600.00, is part of the Rapid Acceleration of Diagnostic Testing (RADX) major program. There is no set-aside designation for this contract, and the place of performance is Bend, Oregon.
Quick answers
Who was awarded contract 75N92021C00008?
75N92021C00008 was awarded to Qorvo Biotechnologies LLC by National Heart Lung and Blood Institute (National Institutes of Health) on April 2, 2021.
How much is contract 75N92021C00008 worth?
The government has obligated $23,882,600 on 75N92021C00008.
Was contract 75N92021C00008 competed?
The extent of competition for 75N92021C00008 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award